Skip to content

Arunaya Organics Ltd. (ARUNAYA)

SME Cap

Industrials stocks · SME cap · NSE

Arunaya Organics Ltd. operates in Organic Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.

₹13.6
+0.35 · +2.64%
Market cap ₹23.5 Cr
Data qualityFresh enough for analysisQuote updated 21 Oct, 03:31 pm IST
Details
Quote21 Oct, 03:31 pm IST
Base fundamentals16 Oct 2026 · screener
Latest result01 Jun, 07:52 pm IST
Score22 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags24 Apr 2026
Coverage13/14 · 93%
Valuation2026-07-20 · Rf 6.8% · Industrials P/E 26.2 (n=537)
Technical timing lens

Trend score and candlestick chart

30Bearish

full bear SMA stack · SMA20 -3.5% / mo · MACD − · near 52W low

Stock trend: 20
Sector RS: 46
Sector 3M: -7.1% vs Nifty 500 -5.6%

Latest mapped FPI equity flow was not positive. View sector evidence

Technical chart

ARUNAYAD candles · FIT view-30.3%
Latest close ₹13.60 on 2026-10-21
Bar
+5.0%
RSI
44
MACD hist
-0.01
52W pos
4%
Visible chart range
Candle interval
2026-10-21O ₹12.95H ₹13.80L ₹12.90C ₹13.60Vol 10,000 sh
₹11.97₹17.07₹22.17₹27.28₹32.3852H52L₹13.60VolRSIMACD2026-042026-062026-082026-092026-11
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context

Relative performance and chart statistics

Adjusted completed-session prices, rebased to 100

ARUNAYANifty India ManufacturingNifty 500
-21%-12%-3%+6%21 Jul3 Sept21 Oct21 Oct 2026ARUNAYA -16.3%Nifty India Manufactu… -7.7%Nifty 500 -6.5%
ARUNAYA
-16.3%
Nifty 500
-6.5%
Nifty India Manufacturing
-7.7%
Vs Nifty 500
-9.8 pp
Chart stats
21 Oct 2026
From 52W high
-56.8%
₹31.5
52W range position
4%
₹12.9 - ₹31.5
ATR (14)
4.0%
₹0.5
Volume vs 20D
1.09x
Latest completed session
Avg traded value
₹0 Cr
20-session average
20D price channel
₹12.9 - ₹15
37.2% annualized volatility
Research snapshot

What the evidence says now

Investable fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is mixed.

Suggested next step
Research, do not rush
The evidence is not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
Legacy · UNDERVALUED
67

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Latest result
Excellent
90

Revenue +32.4% · PAT +100.0% YoY

Technical
Bearish
30

Price trend and sector-relative-strength timing.

Valuation
Legacy model
+89.6%

Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.

Trust
Limited evidence
70

Financial-only signal; management claim evidence is not sufficient yet.

Financials

Fundamentals, quarterly history, margins, returns and balance-sheet evidence

Latest result

Quarter ended 31 Mar 2026

Excellent · 90/100

Rev +32% YoY · PAT +100% YoY · margin expansion · operating leverage

Filed 31 Mar 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹49 Cr+32.4%-9.3%
EBITDA₹3 CrNDF+0.0%
Operating margin7.0%NDF+100 bps
PAT₹2 Cr+100.0%+0.0%
PAT margin4.1%NDF+38 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Fundamentals

Valuation

P/E
5.76
P/B
—
EV/EBITDA
5.11
Market Cap
23.50Cr

Profitability

ROE
44.10%
ROCE
32.50%
ROA
9.05%
Dividend Y
—

Growth (CAGR)

Revenue 5Y
0.24%
EPS 5Y
73.21%
Revenue 3Y
36.00%
EPS 3Y
36.00%

Balance Sheet

Debt/Equity
1.18
Interest Coverage
4.06×
Altman Z
2.71
Book Value
—

Cash Flow

FCF Yield
8.68%
FCF Positive Y
1/5
OCF
2.50 Cr
EPS TTM
3.32

Shareholding

Promoter Hold
60.79%
Promoter Pledge
0.00%
Momentum 52W
2%

Financial History

Updated 21/10/2026

Revenue

₹ Cr
Latest: 61.8-17.9% vs prev
075.3Mar 2022: 61.5Mar 2023: 75.3Mar 2024: 61.8FY22FY23FY24

Net Profit

₹ Cr
Latest: 4.1+133.1% vs prev
04.1Mar 2022: 1.4Mar 2023: 1.8Mar 2024: 4.1FY22FY23FY24

Return on Equity

%
Latest: 36.2+50.0% vs prev
036.2Mar 2022: 28.6%Mar 2023: 24.1%Mar 2024: 36.2%FY22FY23FY24

Technicals

Trend interpretation, Stage 2, relative strength, volume and indicator evidence

Daily technical trend read

Mixed signals

Signals are conflicting — long-term trend down. RSI 44. Wait for confirmation.

  • Price < SMA20 < SMA50 < SMA200 — full bearish stack.
  • SMA20 falling (~3.7% over last month) — short-term momentum negative.
  • RSI(14) at 44 — rising, no extreme reading.
  • MACD below signal but histogram contracting — bearish momentum easing.
  • 57% off 52W high · 5% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

17
RS percentile
Stage 4 Downtrend
1M return
-4.9%
3M return
-17.3%
6M return
-20.0%
1Y return
-41.0%
RS 1D
+4
RS 20D
+9
Sector rank
#2
Industry rank
#6
Stage evidence
  • Price is 21.5% below the 30-week proxy.
  • The 50-DMA is below the 30-week proxy and its slope is falling -4.1%.
  • Both 3-month and 6-month returns are negative.
50-DMA
price below
200-DMA
price below
Sector
leading
Industry
leading
Relative-strength line vs Nifty 500 (base 100)
242 observations
21 Oct 2026Value 61.44+3.61%
567695115135Sept 25Feb 26Jun 26Oct 2661
RS vs Nifty 50061

Valuation & peers

U-Score 67 · legacy U-Score band UNDERVALUED · valuation evidence and comparable companies

67U-SCORE
Deep Value

Fundamental score breakdown

U band · UNDERVALUED
Valuation24/30
Growth14/25
Quality20/20
Balance Sheet6/15
Cash Flow5/10
Piotroski
7/9 (+5)
Penalties
-7
Raw sum
67

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

67/100 · legacy band UNDERVALUED

Positive drivers

  • FCF yield is supportive at 8.7%.
  • Piotroski is strong at 7/9.
  • Fair-value margin of safety is positive at 89.6%.

Main drags

  • Penalty bucket subtracts 7 points.
  • Balance sheet is weaker at 6/15; verify the latest quarterly trend.
  • Cash flow is weaker at 5/10; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
5.8
PB
—
EV/EBITDA
5.1
ROE
44.1%
ROCE
32.5%
FCF Yield
8.7%
Debt/Equity
1.2
MoS
+89.6%
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE. Current PE is low at 5.8, so peak-cycle earnings risk should be checked. Debt/equity is 1.2, so downturn resilience matters.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 22 Oct 2026
v4.3-runtime-valuation
Final score
67
Previous: 67
Legacy U-Score band
UNDERVALUED
Previous: UNDERVALUED
Margin of safety
+89.6%
Previous: +89.6%

Score history

12 stored score snapshots. Latest stored move: +0 points.

22 Oct 2026
v4.3-runtime-valuation
67
67
67
67
67
67
67
67
67
67
67
67

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
—
Growth-justified P/E
39.3
Growth-justified Value
₹130.48
+89.6% MoS
PEG
0.10

Comparable companies

Peers

Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.

Compare all ↗
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
MCON
SME
Mcon Rasayan India Ltd.
Specialty Chemicals
match 133
57
9.8
8.8%
+74%
FAIR VALUE
VSCL
SME
VADIVARHE SPECIALITY CHEMICALS LTD.
Specialty Chemicals
match 129
18
—
—
—
OVERVALUED
YCCL
SME
Yasons Chemex Care Ltd.
Specialty Chemicals
match 129
22
17.5
2.3%
-816%
OVERVALUED
RITEZONE
SME
Rite Zone Chemcon India Ltd.
Specialty Chemicals
match 128
53
21.2
2.2%
+41%
FAIR VALUE
SNEHAA
SME
Snehaa Organics Ltd.
Specialty Chemicals
match 126
77
5.6
24.2%
+88%
DEEP VALUE

Business, management & trust

Growth engines, risks, management commitments and evidence-backed delivery

Business and thesis

Issuer presentation review pending

Arunaya Organics Ltd. operates in Organic Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 31 Mar 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.

Trust Score
70Limited evidence · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Limited evidence: Claim history is still being built. It ranks around the 63rd percentile of the scored universe and 60th percentile within Industrials. Main check: balance sheet trust is weak at 53/100.

This is a financial-behaviour screen, not a claim-tested management reliability verdict.

Computed 05 Sept 2026
management-trust-v1
0 docs text-extracted · 0 concalls text-extracted
Score band
Limited evidence

Financial behaviour is scored, but management claims do not yet have enough outcome checks.

Relative rank
63rd percentile

overall median 67 · Industrials: 60th pctile, median 68 · SME: 81st pctile, median 64

Evidence depth
Financial-only

0 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Limited evidence · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
86
strong · holding, pledge, alignment
Cash flow
65
acceptable · profit to cash conversion
Balance sheet
53
watch · leverage and solvency
Discipline
90
strong · capital discipline
Results
55
watch · quarterly consistency

Trust positives

  • ▸Promoter holding is 60.8%.
  • ▸Promoter pledge is zero.
  • ▸FCF yield is 8.1%.
  • ▸ROCE is 32.5%.

Trust risks

  • ▸Only 1 years of positive FCF.
  • ▸Debt/equity is 1.18.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Important announcements & filings

Latest exchange and company disclosures found within the past two years.

2 shown
Annual reportMar 2026

Mar 2026 · Annual Report 2026

Source: Nse

Open source ↗
Annual reportMar 2025

Mar 2025 · Annual Report 2025

Source: Nse

Open source ↗
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.